Welcome to the Paul Talks Science podcast. On this episode, I have a timely and important conversation about the race to develop a vaccine for the Marburg virus. Marburg is a rare but deadly viral haemorrhagic fever that has recently emerged in Rwanda, sparking global concern.

Read my interview with the health minister of Rwanda on how the country is controlling the disease. The interview was published by Scientific American, and you can read it here.

You can read an article that I wrote for The Lancet on the Marburg virus vaccine efforts here.

Joining me on this podcast is Mark Feinberg, the President and CEO of the International AIDS Vaccine Initiative (IAVI). IAVI has been working on a Marburg vaccine candidate for years, and their efforts have taken on new urgency with this latest outbreak.

In this interview, Mark will share insights on IAVI's vaccine development process, the current state of the pipeline, and the challenges of preparing for unpredictable outbreaks like Marburg. We'll also discuss the broader landscape of global health preparedness and the need for coordinated responses to emerging infectious diseases.

This is a fascinating look at the high-stakes work happening behind the scenes to protect us from deadly viruses. Let's dive into the conversation.